1.Two Cases of Herpes Zoster in healthy Children after Varicella Vaccination.
Sung Jun KIM ; Yong Suk LEE ; Seung Ri SEO ; Duk Kyu CHUN ; Jong Rok LEE ; Seung Chul LEE
Korean Journal of Dermatology 2001;39(2):250-252
Herpes zoster is an uncommon disease in children, especially in healthy children. The clinical studies and observations of herpes zoster has been focused to children with hemato-oncologic diseases or immuno-compromised conditions. Recently the association of herpes zoster after varicella vaccine (Oka strain) immunization has been concerned and some cases of normal children after varicella vaccination have been reported. We experienced two cases of herpes zoster in healthy children after varicella vaccination.
Chickenpox Vaccine
;
Chickenpox*
;
Child*
;
Herpes Zoster*
;
Humans
;
Immunization
;
Vaccination*
2.A Case of Subcutaneous Folliculosebaceous Cystic Hamartoma.
Sang Jai JANG ; Sung Jun KIM ; Seung Ri SEO ; Yong Suk LEE ; Duk Kyu CHUN ; Bang Soon KIM
Korean Journal of Dermatology 2002;40(4):458-460
Folliculosebaceous cystic hamartoma(FSCH) is a rare cutaneous hamartoma of follicular, sebaceous, and mesenchymal elements. The tumor usually has sessile or pedunculated papule or nodule and occurs frequently in the center of face and sometimes on the scalp, ear, and trunk. We report a case of FSCH, which a 36-year-old woman presented as a subcutaneous nodule on the occipital area of scalp. Histologic examination of the nodule showed a central large cystic structure connected with numerous sebaceous lobules, and stroma consisted of delicate fibrillary bundles of collagen in concert with dilated capillaries and venules, as well as with adipocytes.
Adipocytes
;
Adult
;
Capillaries
;
Collagen
;
Ear
;
Female
;
Hamartoma*
;
Humans
;
Mesoderm
;
Scalp
;
Venules
3.Klebsiella Pneumoniae Associated Extreme Plasmacytosis.
Yeonsook MOON ; Woo Ri JANG ; Hyeon Gyu YI ; In Seo PARK ; Chung Hyun NAHM ; Jong Weon CHOI ; Jin Ju KIM ; Seung Baik HAN
Infection and Chemotherapy 2013;45(4):435-440
Infection-associated plasmacytosis is not uncommon; however, marked plasmacytosis in both peripheral blood and bone marrow that mimicks plasma cell leukemia is a very rare condition. We encountered a case of extreme plasmacytosis associated with Klebsiella pneumoniae sepsis in an aplastic anemia patient. A 42-year-old man presented with high fever of 5 days' duration. Hematological analysis revealed severe neutropenia and thrombocytopenia; his white blood cell count was 900/mm3, with 26% of plasma and plasmacytoid cells in peripheral blood. Bone marrow biopsy and aspiration showed 25% cellularity with marked plasmacytosis (80%), highly suggestive of plasma cell leukemia. On the eighth hospital day, K. pneumoniae was identified in blood and sputum cultures. Fever improved after switching antibiotics, although his hematological condition worsened. His bone marrow cellularity (plasma cell proportion) progressively decreased: the values were 25% (80%), 10% (26%), 10% (11%), and < 10% (< 4%) on the 8th, 30th, 60th, and 90th hospital day, respectively. His plasmacytosis was extremely severe but was confirmed to be reactive with polyclonality. The present case represents the first report of strong suspicion of K. pneumoniae sepsis-associated marked plasmacytosis in an aplastic anemia patient.
Adult
;
Anemia, Aplastic
;
Anti-Bacterial Agents
;
Biopsy
;
Bone Marrow
;
Fever
;
Humans
;
Klebsiella pneumoniae*
;
Klebsiella*
;
Leukemia, Plasma Cell
;
Leukocyte Count
;
Neutropenia
;
Plasma
;
Plasma Cells
;
Pneumonia
;
Sepsis
;
Sputum
;
Thrombocytopenia
4.Relationship between high bile juice amylase levels and chronic bacterial infections in patients with gallbladder cancer
Young Mok PARK ; Hyung Il SEO ; Suk KIM ; Seung Baek HONG ; Nam Kyung LEE ; Dong Uk KIM ; Sung Yong HAN ; So Jeong LEE ; Jae Ri KIM
Annals of Surgical Treatment and Research 2022;102(3):125-130
Purpose:
Pancreatic enzyme reflux into the biliary tract is associated with chronic inflammation and increased cellular proliferation in the biliary epithelium, leading to biliary carcinoma. We evaluated the relationship between high bile juice amylase levels and biliary microflora in patients with malignant gallbladder lesions.
Methods:
In this retrospective study, 25 gallbladder specimens were obtained from patients with gallbladder cancer to evaluate amylase levels and perform bacterial culture. The samples were divided into high and low amylase groups and culture-positive and negative groups for analysis. Bile juice amylase 3 times higher than the normal serum amylase level (36–128 IU/L) was considered high.
Results:
The number of positive cultures was higher in the high amylase group than in the low amylase group, but the difference was insignificant. There were no differences in other clinicopathological factors. Sixteen patients showed positive culture results; Escherichia coli and Klebsiella spp. were the most common gram-negative bacteria, whereas Enterococcus and Streptococcus spp. were the most common gram-positive bacteria. Age and bile juice amylase levels were significantly higher in the culture-positive group than in the culture-negative group. The incidence of bacterial resistance to cephalosporins was 6.25%–35.29%, and this incidence was particularly high for lower-generation cephalosporins.
Conclusion
Bacteria in gallbladder were identified more frequently when the amylase level was high. High amylase levels in the gallbladder can be associated with caused chronic bacterial infections with occult pancreaticobiliary reflux, potentially triggering gallbladder cancer
5.Social Inequities in the Survival of Liver Cancer: A Nationwide Cohort Study in Korea, 2007–2017
Mia SON ; Hye-Ri KIM ; Seung-Ah CHOE ; Seo-Young SONG ; Kyu-Hyoung LIM ; Myung KI ; Yeon Jeong HEO ; Minseo CHOI ; Seok-Ho GO ; Domyung PAEK
Journal of Korean Medical Science 2024;39(12):e130-
Background:
To analyze the effects of socioeconomic status (type of insurance and income level) and cancer stage on the survival of patients with liver cancer in Korea.
Methods:
A retrospective cohort study was constructed using data from the Healthcare Big Data Platform project in Korea between January 1, 2007, and December 31, 2017. A total of 143,511 patients in Korea diagnosed with liver cancer (International Classification of Diseases, 10th Revision [ICD-10] codes C22, C220, and C221) were followed for an average of 11 years. Of these, 110,443 died. The patient’s insurance type and income level were used as indicators of socioeconomic status. Unadjusted and adjusted hazard ratios (HRs) and 95% confidence intervals (CIs) were calculated using a Cox proportional hazards regression model to analyze the relationship between the effects of sex, age, and cancer stage at first diagnosis (Surveillance, Epidemiology, and the End Results; SEER), type of insurance, and income level on the survival of patients with liver cancer. The interactive effects of the type of insurance, income level, and cancer stage on liver cancer death were also analyzed.
Results:
The lowest income group (medical aid) showed a higher risk for mortality (HR (95% CI); 1.37 (1.27–1.47) for all patients, 1.44 (1.32–1.57) for men, and 1.16 (1.01–1.34) for women) compared to the highest income group (1–6) among liver cancer (ICD-10 code C22) patients. The risk of liver cancer death was also higher in the lowest income group with a distant cancer stage (SEER = 7) diagnosis than for any other group.
Conclusion
Liver cancer patients with lower socioeconomic status and more severe cancer stages were at greater risk of death. Reducing social inequalities is needed to improve mortality rates among patients in lower social class groups who present with advanced cancer.
6.Impact of Early Initiation of Dialysis on Clinical Outcome.
La Young YOON ; Hyeon Jeong GOONG ; Se Hun KIM ; Koung Ah PARK ; Byung Chul YOU ; Yu Ri SEO ; Seung Sik PARK ; Eun Jung KIM ; Soo Jeong CHOI ; Moo Yong PARK ; Jin Kuk KIM ; Seung Duk HWANG
Soonchunhyang Medical Science 2011;17(1):25-28
OBJECTIVE: Current guidelines for initiating dialysis therapy are based on level of kidney function and clinical evidence of uremia. In several studies, early dialysis showed no benefit in mortality and complication rate. Thus we examined whether the timing of initiation of dialysis influenced mortality and complication rate with renal failure. METHODS: We retrospectively studied the clinical outcomes in 290 patients with renal failure who underwent dialysis therapy from 2001 to 2009. The early and late dialysis group defined as values more than and less than 10 mL/min/1.73 m2. The primary outcome was death from any cause and the secondary outcome was complication event. RESULTS: The survival rates and complication events were compared based on the estimated glomerular filtration rate, the survival rate in late dialysis group is better than in early dialysis group and the significant prognostic factors determined by multivariate analysis were age and residual renal function at time of initiation of dialysis. No difference in complication events were observed. Subgroup analysis in hemodialysis group shows no significant difference in survival rate. CONCLUSION: The survival rate in late dialysis group is better than in early dialysis group. And the complication rate were not different in two groups.
Dialysis
;
Glomerular Filtration Rate
;
Humans
;
Kidney
;
Kidney Failure, Chronic
;
Multivariate Analysis
;
Renal Dialysis
;
Renal Insufficiency
;
Retrospective Studies
;
Survival Rate
;
Uremia
7.A reduced dose of ribavirin does not influence the virologic response during pegylated interferon alpha-2b and ribavirin combination therapy in patients with genotype 1 chronic hepatitis C.
Byung Chul YOU ; Young Seok KIM ; Hun Il KIM ; Se Hun KIM ; Seung Sik PARK ; Yu Ri SEO ; Sang Gyune KIM ; Se Whan LEE ; Hong Soo KIM ; Soung Won JEONG ; Jae Young JANG ; Boo Sung KIM
Clinical and Molecular Hepatology 2012;18(3):272-278
BACKGROUND/AIMS: When combined with pegylated interferon alpha-2b (Peg-IFN alpha-2b) for the treatment of genotype 1 chronic hepatitis C (CHC) in Korea, the current guideline for the initial ribavirin (RBV) dose is based on body weight. However, since the mean body weight is lower for Korean patients than for patients in Western countries, current guidelines might result in Korean patients being overdosed with RBV. METHODS: We retrospectively reviewed the medical records of patients with genotype 1 CHC who were treated with Peg-IFN alpha-2b and RBV combination therapy. We divided the patients into groups A (> or =15 mg/kg/day, n=23) and B (<15 mg/kg/day, n=26), given that the standard dose is 15 mg/kg/day. The clinical course in terms of the virologic response, adverse events, and dose modification rate was compared between the two groups after therapy completion. RESULTS: The early response rates (92.0% vs. 83.3%, P=0.634) and sustained virologic response rates (82.6% vs. 73.1%, P=0.506) did not differ significantly between the two groups. During the treatment period, the RBV dose reduction rate was significantly higher in group A than in group B (60.9% vs. 23.1%, P=0.01). CONCLUSIONS: RBV dose reduction is performed frequently when patients are treated according to the current Korean guidelines. Given that lowering the RBV dose did not appear to decrease the virologic response during therapy, reducing RBV doses below the current Korean guideline may be effective for treatment, especially in low-weight patients.
Antiviral Agents/pharmacology/*therapeutic use
;
Body Mass Index
;
Body Weight
;
Dose-Response Relationship, Drug
;
Drug Administration Schedule
;
Drug Therapy, Combination
;
Female
;
Genotype
;
Hepacivirus/drug effects
;
Hepatitis C, Chronic/*drug therapy/virology
;
Humans
;
Interferon-alpha/pharmacology/*therapeutic use
;
Male
;
Polyethylene Glycols/pharmacology/*therapeutic use
;
RNA, Viral/analysis
;
Recombinant Proteins/pharmacology/therapeutic use
;
Retrospective Studies
;
Ribavirin/pharmacology/*therapeutic use
;
Sex Factors
;
Treatment Outcome
8.The 2024 Guidelines for Osteoporosis - Korean Society of Menopause: Part II
Dong Ock LEE ; Yeon Hee HONG ; Moon Kyoung CHO ; Young Sik CHOI ; Sungwook CHUN ; Youn-Jee CHUNG ; Seung Hwa HONG ; Kyu Ri HWANG ; Jinju KIM ; Hoon KIM ; Dong-Yun LEE ; Sa Ra LEE ; Hyun-Tae PARK ; Seok Kyo SEO ; Jung-Ho SHIN ; Jae Yen SONG ; Kyong Wook YI ; Haerin PAIK ; Ji Young LEE
Journal of Menopausal Medicine 2024;30(2):55-77
9.Corrigendum: 2023 Korean Society of Menopause - Osteoporosis Guidelines Part I
Dong Ock LEE ; Yeon Hee HONG ; Moon Kyoung CHO ; Young Sik CHOI ; Sungwook CHUN ; Youn-Jee CHUNG ; Seung Hwa HONG ; Kyu Ri HWANG ; Jinju KIM ; Hoon KIM ; Dong-Yun LEE ; Sa Ra LEE ; Hyun-Tae PARK ; Seok Kyo SEO ; Jung-Ho SHIN ; Jae Yen SONG ; Kyong Wook YI ; Haerin PAIK ; Ji Young LEE
Journal of Menopausal Medicine 2024;30(2):126-126
10.The 2024 Guidelines for Osteoporosis - Korean Society of Menopause: Part II
Dong Ock LEE ; Yeon Hee HONG ; Moon Kyoung CHO ; Young Sik CHOI ; Sungwook CHUN ; Youn-Jee CHUNG ; Seung Hwa HONG ; Kyu Ri HWANG ; Jinju KIM ; Hoon KIM ; Dong-Yun LEE ; Sa Ra LEE ; Hyun-Tae PARK ; Seok Kyo SEO ; Jung-Ho SHIN ; Jae Yen SONG ; Kyong Wook YI ; Haerin PAIK ; Ji Young LEE
Journal of Menopausal Medicine 2024;30(2):55-77